Clinical trial
Intermittent Preventive Treatment With Antimalarials in Kenyan Infants
NCT00111163 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00111163 |
|---|---|
| Title | Intermittent Preventive Treatment With Antimalarials in Kenyan Infants |
| Official title | Efficacy and Safety of Pediatric Immunization-linked Preventive Intermittent Treatment With Antimalarials in Decreasing Anemia and Malaria Morbidity in Rural Western Kenya |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Kenya Medical Research Institute Bill and Melinda Gates Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Malaria, Anemia |
| Intervention type | Drug |
| Interventions | sulfadoxine-pyrimethamine with artesunate, amodiaquine with artesunate, chlorproguanil-dapsone |
| Enrollment | 1,516 |
| Start date | Mar 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | May 18, 2005 |
| Last update posted | Sep 27, 2012 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: